Rheumatic manifestations in HIV-1 infected in-patients and literature review

Clinical and Experimental Rheumatology

Volumn 26, Issue 5, 2008, Pages 799-806

  Yao, Qingping ^a,c   Frank, Marcella ^b   Glynn, Martin ^b   Altman, Roy D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Capital Health System   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

AIDS; Connective tissue disease; HIV; Osteonecrosis; Rheumatic manifestation; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTHRALGIA; AVASCULAR NECROSIS; BACTERIAL ARTHRITIS; CONNECTIVE TISSUE DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OSTEOMYELITIS; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SPONDYLOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; NEW JERSEY; PREVALENCE; RETROSPECTIVE STUDIES; RHEUMATIC DISEASES; YOUNG ADULT;

EID: 57349170837     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. + T-Cell determinations with CD45 gating for persons infected with human immunodeficiency virus. MMWR 2003; (RR-02): 1-13.
2. CENTERS FOR DISEASE CONTROL: Pneumocystis carinii pneumonia. MMWR 1981; 30: 250-2.
3. CENTERS FOR DISEASE CONTROL: Kaposi's sarcoma and pneumocystis pneumonia among homosexual men. MMWR 1981; 30: 305-8.
4. BERMAN A, CAHN P, PEREZ H et al.: Prevalence and characteristics of rheumatic manifestations in patients infected with human immunodeficiency virus undergoing antiretroviral therapy. J Rheumatol. 1997; 24: 2492.
5. BERMAN A, ESPINOZA LR, DIAZ JD et al.: Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 1998; 85: 59-64.
6. MUNOZ FERNANDEZ S, CARDENAL A, BALSA A et al.: Rheumatic manifestations in 556 patients with human immunodeficiency virus infection. Semin Arthritis Rheum 1991; 21: 30-9,
7. CALABRESE LH: Rheumatic manifestations of HIV infections. Cleve Clin J Med 1993; 60: 484-5.
8. CALABRESE LH, KIRCHNER E, SHRESTHA R: Rheumatic complications of human immunodeficiency virus infection in the era of highly active anti-retroviral therapy: Emergence of new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 2005; 35: 166-74.
9. DEAN HD, STEELE CB, SATCHER AJ, NAKASHIMA AK: HIV/AIDS among minority races and ethnicities in the United States. J Natl Med Assoc 2005; 97: 5S-12S.
10. KOPELMAN RG, ZOLLA-PAZNER S: Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988; 84: 82-8.
11. CALZA L, MANFREDI R, COLANGELI V, A'ANTUONO A, PASSARINI B, CHIODO F: Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy, Int J STD AIDS 2003; 14: 356-9.
12. NALEWAY AL, DAVIS ME, GREELEE RT, WILSON DA, MCCARTY DJ: Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 2005; 14: 862-6.
13. WANG J, YANG S, CHEN JJ AI et al.: Systemic lupus erythematosus: a genetic epidemiology study of 695 patients from China. Arch Dermatol Res 2007; 298: 485-91.
14. ZHANG X, LI H, LI T, ZHANG F, HAN Y: Distinctive rheumatic manifestations in 98 patients with human immunodeficiency virus infection in china. J Rheumatol 2007; 34: 1760-4.
15. DRAKE WP, BYRD VM, OLSEN NJ: Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for AIDS. J Clin Rheumatol 2003; 9: 176-80.
16. PALACIOS R, SANTOS J, VALDIVIELSO P, MARQUEZ M: Human immunodeficiency virus infection and systemic lupus erythematosus: An unusual case and a review of the literature. Lupus 2002; 11: 60-3.
17. DAIKH BE, HOLYST MM: Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: Case report and literature review. Semin Arthritis Rheum 2001; 30: 18-25.
18. MOLINA JF, CITERA G, ROSLER D et al.: Coexistence of human immunodeficiency virus infection and systemic lupus erytheromatosus. J Rheumatol 1995; 22: 347-50.
19. + T cell response in HIV-infective patients. Blood 2004; 104: 3249-56.
20. MITTLEMAN BB, MORSE HCR, PAYNE SM, SHEARER GM, MOZES E: Amelioration of experimental SLE by retrovirus infection. J Clin Immunol 1996; 16: 230-6.
21. CHOWDHRY IA, TAN IJ, MIAN N, MACKAY M, KEISER H, DAVIDSON A: Systemic lupus erythematosus presenting with features suggestive of human immunodeficiency virus infection. J Rheumatol 2005; 32: 1365-8.
22. SHAH SN, HE CJ, KLOTMAN P: Update on HIV-associated nephropathy. Curr Opin Nephrol Hypertens 2006; 15: 450-5.
23. SPERBER K, KALB TH, STECHER VJ, BANERJEE R, MAYER L: Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses 1993; 9: 91-8.
24. FIRP RJ, ZHU H, MORELLI G et al.: Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation. Liver Transpl 2006; 12:51-7.
25. HAZARIKA I, CHAKRAVARTY BP, DUTTAS NM: Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide. Clin Rheumatol 2006; 25: 98-100.
26. BIJLSMA JS, DERKSEN RW, HUBER-BRUNING O, BORLEFFS JC: Does AIDS "cure" rheumatoid arthritis? Ann Rheum Dis 1988; 47: 350-1.
27. CALABRESE LH, WILKE WS, PERKINS AD, TUBBS RR: Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjogren's syndrome. Arthritis Rheum 1989; 32: 1453-7.
28. KER KD, SPIERA H: The coexistence of active classic rheumatoid arthritis and AIDS. J Rheumatol 1991; 18: 1739-40.
29. ORNSTEIN MH, KERR LD, SPIERA H: A re-examiation of the relationship between active rheumatoid arthritis and the acquired immunodeficiency syndrome. Arthritis Rheum 1995; 38: 1701-6.
30. WEGRZYN J, LIVROZET J-M, TOURAINE J-L, MIOSSEC P: Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: Possible contribution of tritherapy. J Rheumatol 2002; 29: 2232-4.
31. PANAYI GS, LANCHBURY SJ, KINGSLEY GH: The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992; 35: 729-35.
32. KAST RE, ALTSCHULER EL: Chaperonin 10 for rheumatoid arthritis. Lancet 2006; 368: 1962.
33. SIVA C, BRASINGTON RD: Worsening of arthritis with antiretroviral therapy: The coexistence of rheumatoid arthritis and human immunodeficiency virus infection revisited. J Clin Rheumatol 2001; 7: 42-6.
34. KAUR PP, CHAN VC, BERNEY SN: Successful etanercept use in an HIV-positive patient with rheumatoid arthritis. J Clin Rheumatol 2007; 13: 79-80.
35. AUTHIER F-J, CHARIOT P, GHERARDI RK: Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 2005; 32: 247-60.
36. STERN R, GOLD J, DICARLO E: Myopathy complicating the acquired immunodeficiency syndrome. Muscle Nerve 1987; 10: 318-22.
37. JOHNSON RW, WILLIAMS FM, KAZI S, DIMACHKIE MM, JDR: Human immunodeficiency virus-associated polymyositis: A longitudinal study of outcome. Arthritis Rheum 2003; 49: 172-8.
38. FUSTER M, NEGREDO E, CADAFALCH J, DOMINGO P, ILLA I, CLAVE P: HIV-associated polymyositis with life-threatening myocardial and esophageal involvement. Arch Intern Med 1999; 159: 1012.
39. ILLA I, NATH A, DALAKAS M: Immunocytochemical and virological characterizatistics of HIV associated inflammatory myopathy: similarities with serolonegative polymyositis. Ann Neurol 1991; 29: 474-81.
40. DAKALAS MC, ILLA I, PEZESHKPOUR GH, LAUKAITIS JP, COHEN B, GRIFFIN JL: Mitochondrial myopathy caused by long-term zodovudine therapy. N Engl J Med 1990; 322: 1098-105.
41. SIKDAR S, GROVER C, KUBBA S et al.: An uncommon cause of scleroderma. Scand J Rheumatol 2005; 34: 242-5.
42. PROKOP J, JAGODZINSKI PP: Identification of retroviral conserved pol sequences in serum of mixed connective tissue disease and systemic sclerosis patients. Biomed Pharmacother 2004; 58: 61-4.
43. SCRIBNER AN, TROTA-CANCIO PV, COX BA et al.: Osteonecrosis in HIV: a case control study. J Acquir Immune Defic Syndrome Retroviral 2000; 25: 19-25.
44. MILLER KD, MASUR H, JONES EC, JOE GO, RICK ME, KELLY GG: High prevalence of osteonecrosis of the femoral head in HIV-infected adults. Ann Intern Med 2002; 37: 17-25.
45. JOHNS DG, GILL MJ: Avascular necrosis in HIV infection. AIDS Patient Care STDs 1999; 13: 1997-8.
46. MARY-KRAUSE M, BILLAUD E, POIZOT-MARTIN I et al.: Clinical Epidemiology Group of the French Hospital Database. Risk factors for osteonecrosis in HIV-infected patients: Impact of treatment with combination antiretroviral therapy. AIDS 2006; 20: 1627-35.
47. BROWN P, CRANE L: Avascular necrosis of bone in patients with human immunodeficiency virus infection: Report of six cases and review of the literature. Clin Infect Dis 2001; 32: 1221-6.
48. CALZA L, MADFREDI R, MASTROIANI A, CHIODO F: Osteonecrosis and highly active antiretroviral therapy during HIV infection: Report of a series and literature review. AIDS Patient Care STDs 2001; 15: 385-8.
49. REDDY R, DAFFARY MN, DELAPENHA R, DUTTA A, OLIVER J, FREDERICK W: Avascular necrosis and protease inhibitors. J Natl Med Assoc 2005; 97:1543-6.
50. SIDDIQUI SA, SMITH AM, MASHOOF AA, BRYK E: Osteonecrosis of femoral head in patients infected with HIV: A report of 4 cases and literature review. Am J Orthop 2004; 33: 618-22.
51. WINCHESTER R, BERNSTEIN DH, FISCHER HD, ENLOW R, SOLOMAN G: The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 1987; 106: 19-26.
52. ESPINOZA LR, BERMAN A, VASEY FB, CAHALIN C, NELSON R, GERMAIN BF: Psoriatic arthritis and acquired immunodeficiency syndrome. Arthritis Rheum 1988; 31: 1034-40.
53. BUSKILA D, GLADMAN DD, LANGEVITZ P, BOOKMAN AA, FANNING M, SALIT IE: Rheumatic manifestations of infection with the human immunodeficiency virus (HIV). Clin Exp Rheumatol 1990; 1990: 567-73.
54. NJOBVU P, MCGIL LP, KERR H, JELLIS J, POBEE J: Spondyloarthropathy and human immunodeficiency virus infection in Zambia. J Rheumatol 1998; 25: 1553-9.
55. CLARK MR, SOLINGER AM, HOCHBERG MG: Human immunodeficiency virus infection is not associated with Reiter's syndrome. Data from three large cohort studies. Rheum Dis Clin North Am 1992; 18: 267-76.
56. SELLAM J, BOUVARD B, MASSON C et al.: Use of infliximab to treat psoriatic arthritis in HIV-positive patients. Joint Bone Spine 2007; 74: 197-200.
57. LINARDAKI G, KATSAROU O, IOANNIDOU P, KARAFOULIDOU A, BOKI K: Effective etanercept treatment for psoriatic arthritis complicating concomitant human immunodeficiency virus and hepatitis C virus infection. J Rheumatol 2007; 34: 1353-5.
58. RYNES RI, GOLDENBERG DL, DIGIACOMO R, OLSON R, HUSSAIN M, VEAZEY J: Acquired immunodeficiency syndrome-associated arthritis. Am J Med 1988; 84: 810-6.
59. WEERATUNGE CN, AOLDAN J, ANSTEAD GM: Jaccoud arthropathy: a rarity in the spectrum of HIV-associated arthropathy. Am J Med Sci 2004; 328:351-3.
60. RODRIQUEZ FM: Rheumatic manifestations of human immunodeficiency virus infection. Rheum Dis Clin N Am 2003: 145-61.
61. ALLROGGEN A, FRESE A, RAHMANN A, GAUBITZ M, HUSSTEDT IW, EVERS S: HIV associated arthritis: Case report and review of the literature. Eur J Med Res 2005; 10: 305-8.
62. BIVIJI AA. PAIEMENT GD, STENBACH LS: Musculoskeletal manifestations of human immunodeficiency virus infection. J Am Acad Orthop Surg 2002; 10: 312-20.
63. REVEILLE JD, WILLIAMS FM: Infection and musculoskeletal conditions: rheumatic complications of HIV infection. Best Pract Res Clin Rheumatol 2006; 20: 1159-79.
64. MARQUEZ J, RESTREPO CS, CANDIA L, BERMAN A, ESPINOZA LR: Human immunodeficiency virus-associated rheumatic disorders in the HAART era. J Rheumatol 2004; 31: 741-6.
65. MEDINA F, HERMIDA C, JARA LJ, BARILE L, VERA O, MIRANDA JM: Staphylococcal arthritis in human immunodeficiency virus infection. Br J Rheumatol 1995; 34: 397-8.
66. ITESU S, BRANCATO LJ, WINCHESTER R: A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet 1989; 26: 466-81
67. ZHANG NZ, SHI CS, YAO QP, PAN GX, WANG LL, WEN ZX et al.: Prevalence of primary Sjogren's syndrome in China. J Rheumatol 1995; 22: 659-61.
68. MASTROIANNI A: Emergence of Sjögren's syndrome in Aids patients during highly active antiretroviral therapy. AIDS Patient Care STDs 2004; 18: 1349-51.
69. BASU D, WILLIAMS FM, AHAN CW, REVEILLE JD: Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum 2006; 55: 466-72.
70. VOULGARELIS M, DAFNI UG, ISENBERG DA, MOUTSOPOULOS HM: Malignant lymphoma in primary Sjögren's syndrome: A multicenter, retrospective, clinical study by the European Concerted action on Sjögren's syndrome. Arthritis Rheum 1999; 42: 1765-72.
71. PAGNOUX C, COHEN P, GUILLEVIN L: Vasculitides secondary to infections. Clin Exp Rheumatol 2006; 24 (Suppl. 41): S71-81.
72. KULTHANAN K, JIAMTON S, OMCHAROEN V, LINPIYAWAN R, RUANGPEERAKUL J, SIVAYATHORN A: Autoimmune and rheumatic manifestations and antinuclear antibody study in HIV-infected Thai patients, Int J Dermatol 2002; 41: 417-22.
73. GARCIA-GARCIA JA, MACIAS J, CASTELLANOS V et al.: Necrotizing granulomatosus vasculitis in advanced HIV infection. J Infect 2003; 47: 333-5.
74. GHERADI R, BELEC L, MHIRI C et al.: The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum 1993; 36: 1164-74.
75. ZANDMAN-GODDARD G, SHOENFELD Y: HIV and autoimmunity. Autoimmu Rev 2002; 1: 329-37.
76. DEAS JE, LIU LG, THOMPSON JJ et al.: Reactivity of sera from systemic lupus erythematosus and Sjogren's syndrome patients with peptides derived from human immunodeficiency virus p24 capsid antigen. Clin Diagn Lab. Immunol 1998; 5: 181-85.